NASDAQ$BTTC

Black Titan Corp · Q4 2016 earnings

Q4 2016 earnings · Reported Mar 16, 2017 (9 years ago) · Investor relations

Mar 16Dec 31, 2016

Total Revenue

$35K

No prior period

EPS (adj)

-$540.00

Previous: -$396.00-36.4%

Capital Expenditures

$75K

Previous: $77K-2.6%

Free Cash Flow

-$2.48M

Previous: -$7.54M+67.1%

Net Income

-$2.33M

Previous: -$2.29M-1.4%

Operating Income

-$3.25M

Previous: -$2.25M-44.6%

Gross Profit

-$2.05M

No prior period

Cash & Equivalents

$14M

Previous: $7.86M+78.3%

Total Assets

$18.7M

Previous: $13.3M+40.5%

Stock-Based Comp

$256K

Previous: $367K-30.2%

Titan Pharmaceuticals · Revenue · Quarterly

$35K

Q4 2016

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation